New research shows that inhibiting overactive LRRK2 enzymes could stabilize Parkinson's disease progression, with Stanford ...

A new weekly injectable drug could transform the lives of more than eight million people living with Parkinson's disease, ...

A progressive neurological disorder affecting 10 million people globally, Parkinson’s can cause disruptive symptoms such as ...

The results of experiments in mice models were "astounding," said biochemist Suzanne Pfeffer of Stanford University.

The company completed a clinical trial at nine centers across the U.S., Europe and Asia before it received FDA approval.

The findings of two recent studies give hope that the disease could one day be reversed in humans—but experts warn that this ...

Currently dopamine replacement medications, like levodopa and dopamine agonists, are the primary treatment for Parkinson's ...

A drug used for Parkinson's disease has been shown to be effective in reducing the symptoms of difficult to treat depression, ...

Researchers at the Lawson Health Research Institute, part of St. Joseph’s Health Care London, are studying Ambroxol, a cough ...

By shutting down a hyperactive enzyme, scientists got damaged brain cells to regrow their lost “antennae” and restart ...

An active ingredient in cough medicines since 1979 has shown promise as a treatment for neuropsychiatric symptoms in ...